Clinical trial

A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of…

NCT00213044 · Population Council, Other · Completed

Key facts

NCT number NCT00213044
Title A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women
Official title A Randomized, Controlled, Double-Blind, Cross-Over Trial of Safety, Effect on Genital Tract HIV Shedding, and Acceptability of Vaginal Use of Carraguard by HIV-Infected Women
Lead sponsor Population Council, Other
Collaborators Centers for Disease Control and Prevention U.S. Fed National Center for HIV STD and TB Prevention National Center for Infectious Diseases Ministry of Health, Thailand Chiang Rai Public Health Office…
Status Completed
Phase Phase 1
Study type Interventional
Conditions HIV Infections
Intervention type Drug
Interventions Carraguard (PC-515)
Enrollment 60
Start date Mar 1, 2003
Completion Jun 1, 2004
First posted Sep 21, 2005
Last update posted Aug 15, 2017
Countries Thailand

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies